Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 153 (2007), 3800-3808; DOI  10.1099/mic.0.2007/009647-0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linge, H. M.
Right arrow Articles by Frick, I.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linge, H. M.
Right arrow Articles by Frick, I.-M.
Agricola
Right arrow Articles by Linge, H. M.
Right arrow Articles by Frick, I.-M.
Microbiology 153 (2007), 3800-3808; DOI  10.1099/mic.0.2007/009647-0
© 2007 Society for General Microbiology

Protein FOG is a moderate inducer of MIG/CXCL9, and group G streptococci are more tolerant than group A streptococci to this chemokine's antibacterial effect

Helena M. Linge1,3, Inka Sastalla2, D. Patric Nitsche-Schmitz2, Arne Egesten3 and Inga-Maria Frick1

1 Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, BMC, B14, SE-221 84 Lund, Sweden
2 Helmholtz Zentrum für Infektionsforschung, Abteilung Mikrobielle Pathogenität, Inhoffenstrasse 7, D-381 24 Braunschweig, Germany
3 Department of Clinical Sciences Lund, Division of Respiratory Medicine and Allergology, Lund University, BMC, B14, SE-221 84 Lund, Sweden

Correspondence
Helena M. Linge
Helena_M.Johansson{at}med.lu.se

Streptococcus dysgalactiae subsp. equisimilis (group G streptococci; GGS) cause disease in humans but are often regarded as commensals in comparison with Streptococcus pyogenes (group A streptococci; GAS). The current study investigated the degree and kinetics of the innate immune response elicited by the two species. This was assessed as expression of the chemokine MIG/CXCL9 and bacterial susceptibility to its bactericidal effect. No significant difference in MIG/CXCL9 expression from THP-1 or Detroit 562 cells was observed when comparing whole GGS or GAS as stimuli. The study demonstrates that protein FOG was released from the bacterial surface directly and by neutrophil elastase. Expression of MIG/CXCL9 following stimulation with soluble M proteins of the two species (the recently described protein FOG of GGS and protein M1 of GAS) was reduced for protein FOG in both the monocytic and the epithelial cell line. When the antibacterial effects of MIG/CXCL9 were examined in conditions of increased ionic strength, MIG/CXCL9 killed GAS more efficiently than GGS. Also in the absence of MIG/CXCL9, GGS were more tolerant to increased salt concentrations than GAS. In summary, both GGS and GAS evoke MIG/CXCL9 expression but they differ in susceptibility to its antibacterial effects. This may in part explain the success of GGS as a commensal and its potential as a pathogen.


Abbreviations: AMPs, antimicrobial peptides; BSA, bovine serum albumin; FOG, fibrinogen-binding protein of GGS; GAS, group A streptococci; GGS, group G streptococci; HSA, human serum albumin; IFN, interferon; MIG, monokine induced by interferon {gamma}







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2007 Society for General Microbiology.